June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Corneal Permeability of Pilocarpine HCl 1.25% with Varying pH Formulations
Author Affiliations & Notes
  • Mile Brujic
    Premier Vision Group, Bowling Green, Ohio, United States
  • Jaya Giyanani
    Allergan, an AbbVie company, Irvine, California, United States
  • William Chang
    Allergan, an AbbVie company, Irvine, California, United States
  • Vrushali Waknis
    Allergan, an AbbVie company, Irvine, California, United States
  • Weston Pack
    Allergan, an AbbVie company, Irvine, California, United States
  • Yumna Shabaik
    Allergan, an AbbVie company, Irvine, California, United States
  • Jennifer Seal
    Allergan, an AbbVie company, Irvine, California, United States
  • Anu V Gore
    Allergan, an AbbVie company, Irvine, California, United States
  • Kelly K Nichols
    University of Alabama at Birmingham, School of Optometry, Birmingham, Alabama, United States
  • Footnotes
    Commercial Relationships   Mile Brujic Allergan (an AbbVie company), Abb Optical, Alcon, Art Optical, Bausch + Lomb, Blephex, Contamac, CooperVision, CSEye, Euclid, Eyevance, Horizon, Johnson & Johnson, Kala, Luneau, Novartis, Optovue, Oyster Point, RVL, Sight Science, Sun Pharma, Tarsus, Tangible Science, Walman Optical, Zea Vision, Code C (Consultant/Contractor); Jaya Giyanani AbbVie Inc, Code E (Employment); William Chang AbbVie Inc, Code E (Employment); Vrushali Waknis AbbVie Inc, Code E (Employment); Weston Pack AbbVie Inc, Code E (Employment); Yumna Shabaik AbbVie Inc, Code E (Employment); Jennifer Seal AbbVie Inc, Code E (Employment); Anu V Gore AbbVie Inc, Code E (Employment); Kelly Nichols Allergan (an AbbVie company), Alcon, Aerie, Axim, Bruder, Dompe, HanAll Bio, Kala, Novartis, Osmotica, Oyster Point, Sight Sciences, Tear Film Innovations, Thea, Tarsus and Visionology, Code C (Consultant/Contractor), Allergan (an AbbVie company), Kala, Tear Science, Code F (Financial Support)
  • Footnotes
    Support  The study was sponsored by Allergan, prior to acquisition by AbbVie
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1814 – F0430. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mile Brujic, Jaya Giyanani, William Chang, Vrushali Waknis, Weston Pack, Yumna Shabaik, Jennifer Seal, Anu V Gore, Kelly K Nichols; Corneal Permeability of Pilocarpine HCl 1.25% with Varying pH Formulations. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1814 – F0430.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Evaluate the in vitro corneal permeability of Pilocarpine HCl 1.25% with varying pH formulations.

Methods : Cornea permeability was assessed using Lonza Human Corneal Epithelial Cells (HCEC) grown in a 24-well Transwell cell culture insert. The permeability of 5 formulations of Pilocarpine HCl 1.25% topical solution with varying pH levels (pH = 4.3, 5.1, 6.06, 7.16, and 7.96) were examined.

Results : Mean Apparent Permeability (Papp) increased as pH increased (0.330, 0.431, 1.19, 0.670, 5.03, 7.02 x 10-6 cm/s) with a dramatic increase in pH above 7 (Figure 1). A significant decrease in Transepithelial Electrical Resistance (TEER) values at 120 minutes was observed compared with baseline for all tested formulations except mannitol control. Despite this decrease, limited permeability of the lower pH formulations suggest that the barrier function of the cell layers was not compromised during the study.

Conclusions : The increase in permeability from pH 4.3 to pH 7.96 may be attributed to increasing un-ionized form of pilocarpine (~0.07% un-ionized at pH 4.3 vs. ~87.6% un-ionized at pH 7.96) in the formulation, as permeability across corneal epithelial layers favor un-ionized molecules. Increased permeability could translate into higher levels of pilocarpine in the anterior chamber and greater or longer activation of the iris sphincter and/or ciliary muscle, the target tissues of Pilocarpine HCl 1.25% to induce the pinhole effect and increase depth of focus.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×